Private Market View

Tubulis

Drug Discovery · Planegg-Martinsried, Germany · Founded 2012 · Privately Held (backing)

Last price · $/share
Implied valuation
$5.8B
Total raised
$618.5M
Last round
Later Stage VC (Series C)
Oct 2025
What is Tubulis worth?
$5.8Blast known valuation

Tubulis last raised $360.7M in its Later Stage VC (Series C) (Oct 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 26 names
  • ·Watchlist + deal alerts for Tubulis
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Oct 2025Later Stage VC (Series C)$360.7M

How Tubulis's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Tubulis, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Tubulis worth?
Tubulis's last known valuation is $5.8B.
How much has Tubulis raised?
Tubulis has raised $618.5M in total funding across 1 recorded rounds.
When did Tubulis last raise?
Tubulis last raised in Oct 2025 (Later Stage VC (Series C)), raising $360.7M.